TDZD-8 pre-treatment in transient middle cerebral artery occlusion - 22/10/14
Abstract |
There is an unmet clinical need to develop neuroprotective agents for cerebrovascular procedures requiring transient cerebral artery occlusion. This study aims to investigate the effects of a single pre-treatment dose of 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8), a glycogen synthase kinase-3β (GSK-3β) inhibitor, in a transient focal cerebral ischemia model. Twenty-eight male adult Wistar rats were subjected to right middle cerebral artery (MCA) occlusion via intraluminal thread technique for 60min under continuously cortical perfusion monitoring by laser-Doppler flowmetry. Rats were divided into two groups: control or treatment groups. In the treated group, TDZD-8 (5mg/kg; intravenously) was administered 10min before the onset of the MCA ischemia. At 24-h reperfusion, the following parameters were evaluated: neurological deficits, brain infarct volume, ipsilateral hemispheric oedema, neuron specific enolase (NSE) plasma levels, parenchyma histology (H–E staining), Fluoro-Jade positive neurons, p-Akt and total Akt expression by western blot analysis and p-Akt-positive nuclei by immunohistochemistry. Infarct volume (P<0.001) and neurological deficits severity (P<0.001) were reduced in TDZD-8 treated group. TDZD-8 attenuated hemispheric oedema (P<0.001), prevented the NSE plasma level increase (P<0.001) and diminished the number of degenerated neurons in the infarct area (P<0.001), as shown by Fluoro-Jade staining. TDZD-8 treated rats showed few signs of perivascular oedema when compared to control group. No variations in total Akt and p-Akt expression were observed; instead immunohistochemistry showed increased p-Akt nucleus translocation in TDZD-8 treated rats (P<0.05). TDZD-8 is a potential pre-treatment intraoperative drug to prevent neuronal injury induced by transitory artery occlusion during cerebrovascular procedures.
Le texte complet de cet article est disponible en PDF.Keywords : GSK-3β inhibitor, Intracranial aneurysm surgery, Ischemia-reperfusion, Neuroprotection, Transient focal cerebral ischemia
Abbreviations : BBB, CBF, CCA, ECA, GSK, H–E, ICA, MCA, NSE, TDZD-8, TTC
Plan
Vol 4 - N° 4
P. 361-367 - octobre 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?